PharmaCielo Ltd. announced that Matteo Pellegrini was appointed to its Board of Directors.
As quoted in the press release:
Mr. Pellegrini is a seasoned international business executive with 25 years of international management and leadership experience with Philip Morris International in numerous European and Asian countries.
He served from 2003 to 2015 as Philip Morris International’s President of Asia, where he spearheaded PMI’s expansion, completing three major acquisitions/mergers while leading the most innovative new product launch ever in the tobacco industry. He is well versed in marketing, sales, finance and M&A, and is noted for his ability to create highly effective teams.
Previously, Mr. Pellegrini led PMI divisions in four countries, as Managing Director of Philip Morris Italy, Phillip Morris France, Philip Morris Spain and Philip Morris Portugal. He was Marketing Director Italy, Business Development Manager for Philip Morris International, and began his tenure at PMI in 1991 as Brand Manager.
“Mr. Pellegrini’s history of success in leading global businesses and business expansion continues to add international leadership strength to our Board of Directors,” said PharmaCielo Ltd. Chairman Simon Langelier. “His successful experience in helping to introduce new products and ways of thinking to a traditional industry in a variety of global markets is expected to translate equally well to helping PharmaCielo, as it similarly addresses the global marketplace.”
About PharmaCielo Ltd.
PharmaCielo Ltd. is a global company privately held and headquartered in Canada, with a focus on processing and supplying all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo’s principal (and wholly-owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its nursery and propagation centre located in Rionegro, Colombia.
The boards of directors and executive teams of both PharmaCielo and PharmaCielo Colombia Holdings are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise. PharmaCielo recognized the significant role that Colombia’s ideal location will play in building a sustainable business in the medical cannabis industry, and the company, together with its directors and executives, has built a compelling business plan focused on supplying the international marketplace.
For further information:
David Gordon, Tel: +1 647 259 3258, David.Gordon@CohnWolfe.ca
(Colombia) Juan Manuel Cuellar, Tel: +57 310 3298776, Juan.M.Cuellar@Sprgroup.biz
Tel: +1 647 560 4640, Toll Free 888 968 8279, Investors@PharmaCielo.com